• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative analysis of staging systems in AL amyloidosis.

作者信息

Muchtar Eli, Therneau Terry M, Larson Dirk R, Gertz Morie A, Lacy Martha Q, Buadi Francis K, Dingli David, Hayman Suzanne R, Kapoor Prashant, Gonsalves Wilson, Kourelis Taxiarchis V, Warsame Rahma, Fonder Amie, Hobbs Miriam, Hwa Yi Lisa, Leung Nelson, Russell Stephen, Lust John A, Lin Yi, Go Ronald S, Zeldenrust Steven, Kyle Robert A, Rajkumar S Vincent, Kumar Shaji K, Dispenzieri Angela

机构信息

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Division of Biostatistics, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Leukemia. 2019 Mar;33(3):811-814. doi: 10.1038/s41375-018-0370-z. Epub 2019 Jan 23.

DOI:10.1038/s41375-018-0370-z
PMID:30675009
Abstract
摘要

相似文献

1
Comparative analysis of staging systems in AL amyloidosis.AL淀粉样变性分期系统的比较分析
Leukemia. 2019 Mar;33(3):811-814. doi: 10.1038/s41375-018-0370-z. Epub 2019 Jan 23.
2
Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.在高敏肌钙蛋白T检测时代，分期系统用于系统性淀粉样变性的风险分层。
Blood. 2019 Feb 14;133(7):763-766. doi: 10.1182/blood-2018-10-875252. Epub 2018 Dec 13.
3
Cutaneous light chain amyloidosis with multiple myeloma: A concise review.伴多发性骨髓瘤的皮肤轻链淀粉样变性：简要综述
Hematol Oncol Stem Cell Ther. 2019 Jun;12(2):71-81. doi: 10.1016/j.hemonc.2018.09.003. Epub 2018 Sep 21.
4
Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: A systematic review and meta-analysis.心脏淀粉样变性中轻链和转甲状腺素相关分类的预后影响：系统评价和荟萃分析。
Hellenic J Cardiol. 2019 Nov-Dec;60(6):375-383. doi: 10.1016/j.hjc.2019.01.015. Epub 2019 Feb 8.
5
Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.开发并验证了一个包含 BNP 的生存分期系统，用于轻链淀粉样变性患者。
Blood. 2019 Jan 17;133(3):215-223. doi: 10.1182/blood-2018-06-858951. Epub 2018 Oct 17.
6
Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients.Mayo 2012心脏分期系统在晚期心脏AL淀粉样变性患者风险分层中的应用有限——对1275例接受统一治疗患者队列的分析
Haematologica. 2024 May 1;109(5):1598-1602. doi: 10.3324/haematol.2023.284348.
7
MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis.MRI 特征追踪应变可预测 AL 淀粉样变性的全因死亡率。
Amyloid. 2018 Jun;25(2):101-108. doi: 10.1080/13506129.2018.1465406. Epub 2018 May 7.
8
Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis.诊断时血清游离轻链水平低的淀粉样变性患者的结局。
Amyloid. 2018 Sep;25(3):156-159. doi: 10.1080/13506129.2018.1490261. Epub 2018 Jul 21.
9
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia.AL 淀粉样变心脏生物标志物分期系统的性能分析，特别关注肾衰竭和心房颤动。
Haematologica. 2019 Jul;104(7):1451-1459. doi: 10.3324/haematol.2018.205336. Epub 2019 Jan 17.
10
First report of MYD88 somatic mutation in IgM-associated light chain amyloidosis.MYD88体细胞突变在IgM相关轻链淀粉样变性中的首次报道。
Amyloid. 2017 Mar;24(sup1):42-43. doi: 10.1080/13506129.2016.1272454.

引用本文的文献

1
AL amyloidosis with elevated peripheral blood cell counts - A frequent association with liver involvement. A single-center retrospective study.外周血细胞计数升高的AL淀粉样变性——与肝脏受累的常见关联。一项单中心回顾性研究。
Leuk Res Rep. 2025 Apr 12;23:100509. doi: 10.1016/j.lrr.2025.100509. eCollection 2025.
2
Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis: State-of-the-Art Review.轻链和转甲状腺素蛋白型心脏淀粉样变患者的心肌肌钙蛋白：最新综述
JACC CardioOncol. 2024 Feb 20;6(1):1-15. doi: 10.1016/j.jaccao.2023.12.006. eCollection 2024 Feb.
3
Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients.
Mayo 2012心脏分期系统在晚期心脏AL淀粉样变性患者风险分层中的应用有限——对1275例接受统一治疗患者队列的分析
Haematologica. 2024 May 1;109(5):1598-1602. doi: 10.3324/haematol.2023.284348.
4
Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment.免疫球蛋白轻链淀粉样变性：诊断与风险评估。
J Natl Compr Canc Netw. 2023 Jan;21(1):83-90. doi: 10.6004/jnccn.2022.7077.
5
Future Directions in Cardiac Amyloidosis.未来在心脏淀粉样变性方面的研究方向。
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):73-77. doi: 10.14797/mdcvj.1071. eCollection 2022.
6
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.拟用于免疫球蛋白轻链淀粉样变性临床试验的心脏终点：淀粉样变性论坛心脏工作组报告。
Circ Heart Fail. 2022 Jun;15(6):e009038. doi: 10.1161/CIRCHEARTFAILURE.121.009038. Epub 2022 Mar 25.
7
Prognostic restaging after treatment initiation in patients with AL amyloidosis.治疗开始后 AL 淀粉样变性患者的预后重新分期。
Blood Adv. 2021 Feb 23;5(4):1029-1036. doi: 10.1182/bloodadvances.2020003782.
8
AL amyloidosis: advances in diagnosis and management.AL型淀粉样变性：诊断与治疗进展
Blood Res. 2020 Jul 31;55(S1):S54-S57. doi: 10.5045/br.2020.S009.
9
New developments in diagnosis, risk assessment and management in systemic amyloidosis.系统性淀粉样变的诊断、风险评估和治疗的新进展。
Blood Rev. 2020 Mar;40:100636. doi: 10.1016/j.blre.2019.100636. Epub 2019 Nov 2.
10
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.AL 淀粉样变性病十年幸存者：特征与治疗模式。
Br J Haematol. 2019 Dec;187(5):588-594. doi: 10.1111/bjh.16096. Epub 2019 Jul 12.